MYOPEP is a new over the counter weight management supplement.The concentrated amount of follistatin peptides enriched in its colostrum powder and a blend of purified botanical extracts inhibit myostatin. MYOPEP is a proprietary amino acid complex capable of inducing a pharmaceutical grade effect in human muscle and adipose fat function. Introduced by LAB RMS in 2012, MYOPEP has been sequenced and bio-engineered to enhance muscle glucose utilization and growth, while reducing the production of fat throughout the body. LAB RMS, the founder and sole distributor of the proprietary peptide-based biopharmaceutical innovation MYOPEP, has leveraged on its years of modern stem cell research to specifically identify and isolate peptide elements that can inhibit muscle receptor sites to deactivate the specialized enzymes, Myostatin, which is primarily responsible for the cessation of myogenesis. This innovation is further solidifed following the company’s pivotal discovery of an isoform of follistatin that can effectuate myostatin inhibition not only at a highly effective rate, but also under a unique self-limiting scheme.This ‘myostatin blocking’ peptide developed by LAB RMS is metabolized after a specific period of time, hence eliminating the possibility of an interminable signaling of muscle growth.
TrustPilot
vor 1 Tag
vor 2 Tagen
